Product correctly added to cart.

discount label
5-Chloro-1-benzofuran-2-carboxamide
View 3D

Biosynth logo

5-Chloro-1-benzofuran-2-carboxamide

CAS: 35351-20-3

Ref. 3D-KBA35120

1g
1,074.00 €
100mg
287.00 €
Estimated delivery in United States, on Monday 9 Sep 2024

Product Information

Name:
5-Chloro-1-benzofuran-2-carboxamide
Description:

5-Chloro-1-benzofuran-2-carboxamide is a synthetic cannabinoid that has been shown to have anticancer activity. It is an agonist of the endocannabinoid receptor, CB2 and inhibits cancer cell proliferation in vitro. 5-Chloro-1-benzofuran-2-carboxamide also prevents the formation of new blood vessels (angiogenesis) in vivo. The drug binds to the bacterial enzyme gyrase, which causes it to break down DNA strands. This causes a cell cycle arrest and results in apoptosis. 5CbzfC was found to be effective against a wide range of cancer cells including breast, prostate, lung, and skin cancers. The mode of action is not yet fully understood but may involve inhibition of protein synthesis or other mechanisms involving G proteins or G protein coupled receptors.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
195.6 g/mol
Formula:
C9H6ClNO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KBA35120 5-Chloro-1-benzofuran-2-carboxamide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".